{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T23:00:02Z","timestamp":1772060402933,"version":"3.50.1"},"reference-count":39,"publisher":"Cambridge University Press (CUP)","issue":"11","license":[{"start":{"date-parts":[[2010,3,5]],"date-time":"2010-03-05T00:00:00Z","timestamp":1267747200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Incarcerated persons comprise about 0\u00b74% of the Croatian population, of whom 25\u201330% misuse drugs. We attempted to determine the structure of the prison population, prevalence of HBV, HCV, HIV markers, co-infections with HBV, HCV and HIV and acute HBV, HCV and HIV infection. In total, 25\u00b79% of prisoners were positive for some markers for viral hepatitis (HBV 11\u00b73%, HCV 8\u00b73%, HBV\/HCV 6\u00b73%). Prevalence of HBV infection in intravenous drug users (IDUs) was 26\u00b72% (highly promiscuous group 20\u00b74%, individuals with psychiatric diseases and personality disorders 16\u00b70%). HCV infection in IDUs was 52\u00b70% and 4\u00b79% in the highly promiscuous group. HBV\/HCV co-infection was registered in 34\u00b79% of prisoners positive for HBV markers (203\/582). Acute HBV infection was detected in 0\u00b75%, and HCV in 1\u00b72%. Only 0\u00b715% (5\/3348) of prisoners were anti-HIV positive. It appears that individuals with psychiatric diseases and personality disorders could be an additional risk population for these viral infections.<\/jats:p>","DOI":"10.1017\/s0950268810000476","type":"journal-article","created":{"date-parts":[[2010,3,5]],"date-time":"2010-03-05T05:26:49Z","timestamp":1267766809000},"page":"1610-1620","source":"Crossref","is-referenced-by-count":23,"title":["Viral hepatitis B, C and HIV infection in Croatian prisons"],"prefix":"10.1017","volume":"138","author":[{"given":"V.","family":"BUREK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"HORVAT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"BUTORAC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"MIKULI\u0106","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2010,3,5]]},"reference":[{"key":"S0950268810000476_ref018","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1017\/S0950268803008318","article-title":"Prevalence and risk factors of HIV hepatitis B and hepatitis C in a forensic population of rapists and child molesters","volume":"130","author":"Giotakos","year":"2003","journal-title":"Epidemiology and Infection"},{"key":"S0950268810000476_ref003","first-page":"13","article-title":"Hepatitis B seroprevalence among intravenous users from Baranya County, Croatia","volume":"4","author":"Kribl","year":"2008","journal-title":"Croatian Journal for Public Health"},{"key":"S0950268810000476_ref020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5694\/j.1326-5377.1997.tb140041.x","article-title":"Hepatitis B and C in New South Wales prisons: prevalence and risk factors","volume":"166","author":"Butler","year":"1997","journal-title":"Medical Journal of Australia"},{"key":"S0950268810000476_ref022","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7253.78"},{"key":"S0950268810000476_ref026","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268806006820"},{"key":"S0950268810000476_ref009","article-title":"Urgent action needed to stop spread of hepatitis B and C in Estonia","volume":"11","author":"Tefanova","year":"2006","journal-title":"Eurosurveillance"},{"key":"S0950268810000476_ref023","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000192069.95819.aa"},{"key":"S0950268810000476_ref033","doi-asserted-by":"publisher","DOI":"10.2217\/17460794.2.5.451"},{"key":"S0950268810000476_ref008","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7323.1209"},{"key":"S0950268810000476_ref001","first-page":"371","article-title":"Epidemiology of hepatitis B and C in Croatia","volume":"59","author":"Lesnikar","year":"2005","journal-title":"Acta Medica Croatica"},{"key":"S0950268810000476_ref030","first-page":"660","article-title":"Hepatis C virus infection among firefighters, emergency medical technicians, and opera medics \u2013 selected locations, United States, 1991\u20132000","volume":"49","year":"2000","journal-title":"Morbidity and Mortality Weekly Reports"},{"key":"S0950268810000476_ref038","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.04.011"},{"key":"S0950268810000476_ref004","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.9322438.x"},{"key":"S0950268810000476_ref012","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00136004"},{"key":"S0950268810000476_ref005","volume-title":"Mountjoy prisoners: a sociological and criminological profile","author":"O'Mahony","year":"1997"},{"key":"S0950268810000476_ref034","first-page":"6","article-title":"Prevalence of HBV and HCV infections and incidence of HCV infection after 3, 6 and 12 months detention in La Sante prison, Paris","volume":"152","author":"Arrada","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"S0950268810000476_ref010","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20375"},{"key":"S0950268810000476_ref037","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20943"},{"key":"S0950268810000476_ref027","first-page":"141","article-title":"Hepatitis C virus transmission in the prison inmate population","volume":"30","year":"2004","journal-title":"Canadian Communicable Disease Report"},{"key":"S0950268810000476_ref006","first-page":"379","volume-title":"Methadone Maintenance Treatment and Other Opioid Replacement Therapies","author":"Dolan","year":"1998"},{"key":"S0950268810000476_ref014","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010833917242"},{"key":"S0950268810000476_ref032","first-page":"289","article-title":"Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection \u2013 New York and Georgia. 2000","volume":"50","year":"2001","journal-title":"Morbidity and Mortality Weekly Reports"},{"key":"S0950268810000476_ref021","first-page":"87","article-title":"Tuberculosis, HIV hepatitis B and risk behaviour in a Belgian prison","volume":"55","author":"Todts","year":"1997","journal-title":"Archives of Public Health"},{"key":"S0950268810000476_ref011","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268899002538"},{"key":"S0950268810000476_ref013","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-6405.2007.00009.x"},{"key":"S0950268810000476_ref015","first-page":"121","article-title":"Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey","volume":"3","author":"Weild","year":"2000","journal-title":"Communicable Disease and Public Health"},{"key":"S0950268810000476_ref016","first-page":"1","article-title":"Prevention and control of infections with hepatitis viruses in correctional settings","volume":"52","year":"2003","journal-title":"Morbidity and Mortality Weekly Reports"},{"key":"S0950268810000476_ref024","first-page":"98","article-title":"Transmission of infectious diseases in prison: results of a study in the prison for women in Vechta, Lower Saxony, Germany","volume":"42","author":"Keppler","year":"1996","journal-title":"Sucht"},{"key":"S0950268810000476_ref025","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/92.1.25"},{"key":"S0950268810000476_ref029","doi-asserted-by":"publisher","DOI":"10.1097\/00043764-200206000-00024"},{"key":"S0950268810000476_ref017","doi-asserted-by":"publisher","DOI":"10.1258\/0956462971919228"},{"key":"S0950268810000476_ref007","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2006.06.011"},{"key":"S0950268810000476_ref019","doi-asserted-by":"publisher","DOI":"10.1080\/080394899426855"},{"key":"S0950268810000476_ref031","first-page":"1153","article-title":"Serious adverse events attributed to nevirapin regiments for postexposure prophylaxis after HIV exposures \u2013 worldwide, 1997\u20132000","volume":"49","year":"2001","journal-title":"Morbidity and Mortality Weekly Reports"},{"key":"S0950268810000476_ref035","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2005.066993"},{"key":"S0950268810000476_ref028","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-842X.1999.tb01278.x"},{"key":"S0950268810000476_ref039","unstructured":"39. Weilandt C , Rotily M . European Network on HIV\/AIDS and Hepatitis Prevention in Prison 2, Annual Report. Commission of the European Communities DG V, Europe against AIDS, 1998, p. 1."},{"key":"S0950268810000476_ref002","first-page":"11","article-title":"Epidemiology of HIV infection and AIDS in Croatia \u2013 an overview","volume":"2","author":"Gjenero-Margan","year":"2006","journal-title":"Collegium Antropologicum"},{"key":"S0950268810000476_ref036","first-page":"060525","article-title":"HIV transmission in part of the US prison system: implications for Europe","volume":"11","author":"Testa","year":"2006","journal-title":"Eurosurveillance"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268810000476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T16:58:38Z","timestamp":1556384318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268810000476\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,5]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0950268810000476"],"URL":"https:\/\/doi.org\/10.1017\/s0950268810000476","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,5]]}}}